LIDDS AB (publ) (STO:LIDDS)
0.0100
-0.0030 (-23.08%)
Jan 21, 2026, 1:00 PM CET
LIDDS AB Market Cap
LIDDS AB has a market cap or net worth of 1.77 million as of January 21, 2026. Its market cap has decreased by -87.56% in one year.
Market Cap
1.77M
Enterprise Value
41.02K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since July 31, 2014, LIDDS AB's market cap has decreased from 105.45M to 1.77M, a decrease of -98.32%. That is a compound annual growth rate of -29.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.77M | -70.45% |
| Dec 30, 2025 | 6.00M | -56.65% |
| Dec 30, 2024 | 13.85M | 87.96% |
| Dec 29, 2023 | 7.37M | -87.49% |
| Dec 30, 2022 | 58.92M | -81.85% |
| Dec 30, 2021 | 324.60M | -25.82% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ExpreS2ion Biotech Holding AB | 52.25M |
| Guard Therapeutics International AB | 43.16M |
| Simris Group AB (PUBL) | 41.60M |
| Modus Therapeutics Holding AB | 35.76M |
| 2cureX AB | 34.64M |
| NanoEcho AB | 21.27M |
| Aptahem AB | 20.97M |
| Novakand Pharma AB | 15.39M |